| Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy (NCT05815160) | Debiopharm International SA | 2023-05-02 |
| AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients (NCT05375539) | Milton S. Hershey Medical Center | 2023-05-02 |
| PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation (NCT05639751) | Prelude Therapeutics | 2023-05-02 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants (NCT05848440) | AstraZeneca | 2023-05-02 |
| A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 (NCT05834595) | Chong Kun Dang Pharmaceutical | 2023-05-02 |
| A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010 (NCT05812417) | Dong-A ST Co., Ltd. | 2023-05-02 |
| Tdap and Biomarkers of Alzheimer's Disease (NCT05183516) | Mindful Diagnostics and Therapeutics, LLC | 2023-05-01 |
| A Clinical Study of Injectable IMM0306 in Combination With Lenalidomide (NCT05771883) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2023-05-01 |
| Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn (NCT06860399) | Damascus University | 2023-05-01 |
| A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function (NCT05835180) | Sagimet Biosciences Inc. | 2023-05-01 |
| CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) (NCT05581030) | H. Lee Moffitt Cancer Center and Research Institute | 2023-05-01 |
| Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer (NCT04149145) | University of Alabama at Birmingham | 2023-05-01 |
| Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular Lymphoma (NCT05152459) | City of Hope Medical Center | 2023-05-01 |
| Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer (NCT05225363) | City of Hope Medical Center | 2023-05-01 |
| Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma (NCT05776407) | Chongqing University Cancer Hospital | 2023-05-01 |
| A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the Blood (NCT05738291) | Boehringer Ingelheim | 2023-05-01 |
| A Study of the Absorption, Metabolism and Excretion of [14C]XZP-3621 in Human (NCT05836805) | Xuanzhu Biopharmaceutical Co., Ltd. | 2023-05-01 |
| Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg (NCT05856630) | Luye Pharma Group Ltd. | 2023-05-01 |
| Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides (NCT05414500) | University of Alabama at Birmingham | 2023-05-01 |
| Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma (NCT05588648) | MedPacto, Inc. | 2023-05-01 |
| Phage Therapy for the Treatment of Urinary Tract Infection (NCT05537519) | Unity Health Toronto | 2023-05-01 |
| 177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer (NCT06250244) | Peking Union Medical College Hospital | 2023-05-01 |
| Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial. (NCT06857318) | Hadassah Medical Organization | 2023-05-01 |
| ECP-1014 Treatment for Patients With Solid Tumor Cancers (NCT04930354) | Euclises Pharmaceuticals, Inc. | 2023-05-01 |
| Single Ascending Dose Safety and Tolerability of NTS-104 Healthy Adults (NCT05547438) | NeuroTrauma Sciences, LLC | 2023-05-01 |
| Turning Dexmedetomidine Into a Powerful Anesthetic That Can be Rapidly and Completely Reversed (NCT04942340) | University of Chicago | 2023-05-01 |
| A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma (NCT05909527) | Guangzhou Bio-gene Technology Co., Ltd | 2023-05-01 |
| Effectivity and Safety of Metronidazole 1% Cream in Rosacea Therapy (NCT05861310) | Dr.dr.Irma Bernadette, SpKK (K) | 2023-05-01 |
| Electrical Neuromodulation for Focal Epilepsy (NCT05844696) | National Taiwan University Hospital | 2023-05-01 |
| Implantable Microdevice for TNBC - Pilot Study (NCT05774886) | Dana-Farber Cancer Institute | 2023-05-01 |
| A Study of JNJ-77474462 (Bermekimab) in Healthy Chinese Participants (NCT05252520) | Janssen Research & Development, LLC | 2023-05-01 |
| Gene Therapy for Wet AMD (NCT05611424) | Frontera Therapeutics | 2023-05-01 |
| Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia (NCT05542095) | Washington University School of Medicine | 2023-05-01 |
| COVID-19 Vaccination Detoxification in LDL-C (NCT05839236) | Yang I. Pachankis | 2023-05-01 |
| Protecting Alzheimer Caregivers Using Technology Through Staying Sharp (NCT05260515) | Oregon Health and Science University | 2023-04-30 |
| CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases (NCT05827835) | Zhejiang University | 2023-04-30 |
| Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene (NCT05529134) | Phoenicis Therapeutics | 2023-04-30 |
| Different Concentrations of Sodium Hypochlorite Affecting Post-endodontic Pain (NCT05840679) | Armed Forces Institute of Dentistry, Pakistan | 2023-04-30 |
| Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B (NCT05808374) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2023-04-30 |
| Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia Gravis (NCT05828225) | Zhejiang University | 2023-04-30 |
| Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults (NCT05799651) | Glycovax Pharma Inc. | 2023-04-28 |
| Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon (NCT05935527) | Peregrine Ophthalmic | 2023-04-28 |
| GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies (NCT05880043) | GI Cell, Inc. | 2023-04-28 |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection (NCT05763576) | Hoffmann-La Roche | 2023-04-28 |
| KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis (NCT05938725) | Kyverna Therapeutics | 2023-04-28 |
| MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (NCT05708924) | Masonic Cancer Center, University of Minnesota | 2023-04-28 |
| A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors (NCT05794477) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2023-04-28 |
| A Study of EBC-129 in Advanced Solid Tumours (NCT05701527) | EDDC (Experimental Drug Development Centre), A*STAR Research Entities | 2023-04-28 |
| A Study of BPI-452080 in Subjects With Solid Tumors (NCT05843305) | Betta Pharmaceuticals Co., Ltd. | 2023-04-28 |
| Clinical Trial of PM54 in Advanced Solid Tumors Patients. (NCT05841563) | PharmaMar | 2023-04-28 |
| Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (NCT05441514) | City of Hope Medical Center | 2023-04-28 |
| A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression (NCT05736731) | A2 Biotherapeutics Inc. | 2023-04-28 |
| To Evaluate the Safety and PK Characteristics in Healthy Volunteers (NCT06355349) | JW Pharmaceutical | 2023-04-28 |
| Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM (NCT04991870) | M.D. Anderson Cancer Center | 2023-04-28 |
| Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer (NCT05943041) | GILongevity | 2023-04-28 |
| CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT (NCT05943067) | University Hospital Tuebingen | 2023-04-27 |
| A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer (NCT05742750) | Sun Yat-sen University | 2023-04-27 |
| Development and Evaluation of Computerized Chemosensory Based Orbitofrontal Networks Training for Treatment of Pain (NCT06218407) | Evon Medics LLC | 2023-04-27 |
| Altering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive Symptoms (NCT06320028) | University of Arizona | 2023-04-27 |
| Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors (NCT05835687) | St. Jude Children's Research Hospital | 2023-04-27 |
| Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol (NCT05896969) | Syneos Health | 2023-04-27 |
| A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis (NCT05728489) | Boehringer Ingelheim | 2023-04-27 |
| UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors (NCT05848999) | Zhejiang University | 2023-04-27 |
| A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors (NCT05784597) | Philogen S.p.A. | 2023-04-27 |
| A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (NCT05823974) | GlaxoSmithKline | 2023-04-27 |
| A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT06087289) | Novakand Pharma AB | 2023-04-26 |
| A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL) (NCT05512390) | AbbVie | 2023-04-26 |
| GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers (NCT05814926) | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 2023-04-26 |
| Safety and Tolerability of DMT in Healthy Adults (NCT05901012) | Universidade Federal do Rio Grande do Norte | 2023-04-26 |
| 5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East Africa (NCT05362955) | UNC Lineberger Comprehensive Cancer Center | 2023-04-26 |
| The Study of Bemnifosbuvir in Healthy Japanese Subjects (NCT05905497) | Atea Pharmaceuticals, Inc. | 2023-04-26 |
| An Electrocardiogram Study to Evaluate the Effect of Vanzacaftor on the QT/QTc Interval in Healthy Participants (NCT05867147) | Vertex Pharmaceuticals Incorporated | 2023-04-26 |
| A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer (NCT05818683) | Janssen Research & Development, LLC | 2023-04-26 |
| Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy (NCT05753462) | Sqy Therapeutics | 2023-04-26 |
| CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission (NCT05707273) | City of Hope Medical Center | 2023-04-26 |
| Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing (NCT05560477) | University of Cincinnati | 2023-04-26 |
| A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants (NCT05841238) | Eli Lilly and Company | 2023-04-26 |
| A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects (NCT05607693) | Jiangsu HengRui Medicine Co., Ltd. | 2023-04-26 |
| Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas (NCT05400109) | David Wald | 2023-04-26 |
| A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors (NCT06508307) | GONGCHU Biotechnology Co., Ltd | 2023-04-26 |
| Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors (NCT05757492) | Coherus Oncology, Inc. | 2023-04-26 |
| A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis. (NCT05965089) | Arxx Therapeutics | 2023-04-25 |
| A Phase I Study of GZR18 Injection in Obese/Overweight Subjects (NCT06548945) | Gan and Lee Pharmaceuticals, USA | 2023-04-25 |
| Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC) (NCT05770882) | Great Novel Therapeutics Biotech & Medicals Corporation | 2023-04-25 |
| Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy Volunteers (NCT06435507) | Innovative Molecules GmbH | 2023-04-25 |
| A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes (NCT05732103) | Chordia Therapeutics, Inc. | 2023-04-25 |
| A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers (NCT05790681) | Novo Nordisk A/S | 2023-04-25 |
| Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus (NCT05268237) | Biolingus | 2023-04-25 |
| The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma (NCT05741359) | Bioray Laboratories | 2023-04-25 |
| Safety, Tolerability, and Pharmacokinetic Evaluations of CKR-051 After Transdermal Administration in Healthy Male Subjects (NCT05833906) | CK Regeon Inc. | 2023-04-25 |
| A Study of LY3819469 in Participants With Impaired and Normal Renal Function (NCT05841277) | Eli Lilly and Company | 2023-04-25 |
| A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors (NCT06462716) | Chengdu Baiyu Pharmaceutical Co., Ltd. | 2023-04-25 |
| A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male Subjects (NCT05768360) | AstraZeneca | 2023-04-25 |
| A Study of GFH925 in Combination With Cetuximab in Previously Untreated Advanced NSCLC Harboring KRAS G12C Mutation (NCT05756153) | Genfleet Therapeutics (Shanghai) Inc. | 2023-04-25 |
| A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C Mutations (NCT05848843) | M.D. Anderson Cancer Center | 2023-04-25 |
| Study of Bemnifosbuvir on Cardiac Repolarization in Healthy Subjects (NCT05905484) | Atea Pharmaceuticals, Inc. | 2023-04-25 |
| Rural Libraries Promoting Walking and Walkability in Their Rural Communities (NCT05677906) | Oregon Health and Science University | 2023-04-25 |
| IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors (NCT05991518) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2023-04-25 |
| Sentinel Cohort REACT (NCT05780801) | Emory University | 2023-04-24 |
| A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus (NCT05866861) | Cugene Inc. | 2023-04-24 |